Literature DB >> 27905421

Consistency in drug response profiling.

John Patrick Mpindi1, Bhagwan Yadav1, Päivi Östling1,2, Prson Gautam1, Disha Malani1, Astrid Murumägi1, Akira Hirasawa1,3, Sara Kangaspeska1, Krister Wennerberg1, Olli Kallioniemi1,2, Tero Aittokallio1,4.   

Abstract

Year:  2016        PMID： 27905421     DOI： 10.1038/nature20171

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

2.  Cancer: Discrepancies in drug sensitivity.

Authors:  John N Weinstein; Philip L Lorenzi
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

3.  Public domain databases for medicinal chemistry.

Authors:  George Nicola; Tiqing Liu; Michael K Gilson
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

4.  Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Authors:  Tea Pemovska; Mika Kontro; Bhagwan Yadav; Henrik Edgren; Samuli Eldfors; Agnieszka Szwajda; Henrikki Almusa; Maxim M Bespalov; Pekka Ellonen; Erkki Elonen; Bjørn T Gjertsen; Riikka Karjalainen; Evgeny Kulesskiy; Sonja Lagström; Anna Lehto; Maija Lepistö; Tuija Lundán; Muntasir Mamun Majumder; Jesus M Lopez Marti; Pirkko Mattila; Astrid Murumägi; Satu Mustjoki; Aino Palva; Alun Parsons; Tero Pirttinen; Maria E Rämet; Minna Suvela; Laura Turunen; Imre Västrik; Maija Wolf; Jonathan Knowles; Tero Aittokallio; Caroline A Heckman; Kimmo Porkka; Olli Kallioniemi; Krister Wennerberg
Journal:  Cancer Discov       Date:  2013-09-20       Impact factor: 39.397

5.  Inconsistency in large pharmacogenomic studies.

Authors:  Benjamin Haibe-Kains; Nehme El-Hachem; Nicolai Juul Birkbak; Andrew C Jin; Andrew H Beck; Hugo J W L Aerts; John Quackenbush
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

6.  The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Authors:  Jordi Barretina; Giordano Caponigro; Nicolas Stransky; Kavitha Venkatesan; Adam A Margolin; Sungjoon Kim; Christopher J Wilson; Joseph Lehár; Gregory V Kryukov; Dmitriy Sonkin; Anupama Reddy; Manway Liu; Lauren Murray; Michael F Berger; John E Monahan; Paula Morais; Jodi Meltzer; Adam Korejwa; Judit Jané-Valbuena; Felipa A Mapa; Joseph Thibault; Eva Bric-Furlong; Pichai Raman; Aaron Shipway; Ingo H Engels; Jill Cheng; Guoying K Yu; Jianjun Yu; Peter Aspesi; Melanie de Silva; Kalpana Jagtap; Michael D Jones; Li Wang; Charles Hatton; Emanuele Palescandolo; Supriya Gupta; Scott Mahan; Carrie Sougnez; Robert C Onofrio; Ted Liefeld; Laura MacConaill; Wendy Winckler; Michael Reich; Nanxin Li; Jill P Mesirov; Stacey B Gabriel; Gad Getz; Kristin Ardlie; Vivien Chan; Vic E Myer; Barbara L Weber; Jeff Porter; Markus Warmuth; Peter Finan; Jennifer L Harris; Matthew Meyerson; Todd R Golub; Michael P Morrissey; William R Sellers; Robert Schlegel; Levi A Garraway
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

7.  Systematic identification of genomic markers of drug sensitivity in cancer cells.

Authors:  Mathew J Garnett; Elena J Edelman; Sonja J Heidorn; Chris D Greenman; Anahita Dastur; King Wai Lau; Patricia Greninger; I Richard Thompson; Xi Luo; Jorge Soares; Qingsong Liu; Francesco Iorio; Didier Surdez; Li Chen; Randy J Milano; Graham R Bignell; Ah T Tam; Helen Davies; Jesse A Stevenson; Syd Barthorpe; Stephen R Lutz; Fiona Kogera; Karl Lawrence; Anne McLaren-Douglas; Xeni Mitropoulos; Tatiana Mironenko; Helen Thi; Laura Richardson; Wenjun Zhou; Frances Jewitt; Tinghu Zhang; Patrick O'Brien; Jessica L Boisvert; Stacey Price; Wooyoung Hur; Wanjuan Yang; Xianming Deng; Adam Butler; Hwan Geun Choi; Jae Won Chang; Jose Baselga; Ivan Stamenkovic; Jeffrey A Engelman; Sreenath V Sharma; Olivier Delattre; Julio Saez-Rodriguez; Nathanael S Gray; Jeffrey Settleman; P Andrew Futreal; Daniel A Haber; Michael R Stratton; Sridhar Ramaswamy; Ultan McDermott; Cyril H Benes
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

8.  Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.

Authors:  Bhagwan Yadav; Tea Pemovska; Agnieszka Szwajda; Evgeny Kulesskiy; Mika Kontro; Riikka Karjalainen; Muntasir Mamun Majumder; Disha Malani; Astrid Murumägi; Jonathan Knowles; Kimmo Porkka; Caroline Heckman; Olli Kallioniemi; Krister Wennerberg; Tero Aittokallio
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379
  8 in total
  25 in total

1.  Safikhani et al. reply.

Authors:  Zhaleh Safikhani; Nehme El-Hachem; Petr Smirnov; Mark Freeman; Anna Goldenberg; Nicolai J Birkbak; Andrew H Beck; Hugo J W L Aerts; John Quackenbush; Benjamin Haibe-Kains
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

2.  Safikhani et al. reply.

Authors:  Zhaleh Safikhani; Nehme El-Hachem; Petr Smirnov; Mark Freeman; Anna Goldenberg; Nicolai J Birkbak; Andrew H Beck; Hugo J W L Aerts; John Quackenbush; Benjamin Haibe-Kains
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

3.  Evaluating the consistency of large-scale pharmacogenomic studies.

Authors:  Raziur Rahman; Saugato Rahman Dhruba; Kevin Matlock; Carlos De-Niz; Souparno Ghosh; Ranadip Pal
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

4.  Computational Pipeline for Rational Drug Combination Screening in Patient-Derived Cells.

Authors:  Paschalis Athanasiadis; Aleksandr Ianevski; Sigrid S Skånland; Tero Aittokallio
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Computational estimation of quality and clinical relevance of cancer cell lines.

Authors:  Lucia Trastulla; Javad Noorbakhsh; Francisca Vazquez; James McFarland; Francesco Iorio
Journal:  Mol Syst Biol       Date:  2022-07       Impact factor: 13.068

6.  A cross-study analysis of drug response prediction in cancer cell lines.

Authors:  Fangfang Xia; Jonathan Allen; Prasanna Balaprakash; Thomas Brettin; Cristina Garcia-Cardona; Austin Clyde; Judith Cohn; James Doroshow; Xiaotian Duan; Veronika Dubinkina; Yvonne Evrard; Ya Ju Fan; Jason Gans; Stewart He; Pinyi Lu; Sergei Maslov; Alexander Partin; Maulik Shukla; Eric Stahlberg; Justin M Wozniak; Hyunseung Yoo; George Zaki; Yitan Zhu; Rick Stevens
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

Review 7.  Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models.

Authors:  Hossein Sharifi-Noghabi; Soheil Jahangiri-Tazehkand; Petr Smirnov; Casey Hon; Anthony Mammoliti; Sisira Kadambat Nair; Arvind Singh Mer; Martin Ester; Benjamin Haibe-Kains
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

8.  PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.

Authors:  Petr Smirnov; Victor Kofia; Alexander Maru; Mark Freeman; Chantal Ho; Nehme El-Hachem; George-Alexandru Adam; Wail Ba-Alawi; Zhaleh Safikhani; Benjamin Haibe-Kains
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies.

Authors:  J Sunil Rao; Hongmei Liu
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

10.  Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.

Authors:  Matthias Kolberg; Jarle Bruun; Astrid Murumägi; John P Mpindi; Christian H Bergsland; Maren Høland; Ina A Eilertsen; Stine A Danielsen; Olli Kallioniemi; Ragnhild A Lothe
Journal:  Mol Oncol       Date:  2017-07-05       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.